Additional file 1: of A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers

León-Cachón, Rafael; Ascacio-Martínez, Jorge; Gamino-Peña, María; Cerda-Flores, Ricardo; Meester, Irene; Gallardo-Blanco, Hugo; Gómez-Silva, Magdalena; Piñeyro-Garza, Everardo; Barrera-Saldaña, Hugo

doi:10.6084/m9.figshare.c.3597698_D3.v1

12885_2016_2062_MOESM1_ESM.docx (33.01 kB)

Additional file 1: of A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers

journal contribution

posted on 2016-02-08, 05:00 authored by Rafael León-Cachón, Jorge Ascacio-Martínez, María Gamino-Peña, Ricardo Cerda-Flores, Irene Meester, Hugo Gallardo-Blanco, Magdalena Gómez-Silva, Everardo Piñeyro-Garza, Hugo Barrera-Saldaña

Allele and genotype frequencies of polymorphism in genes involved in drug metabolism and response. HWE = Hardy-Weinberg equilibrium, P = gene present, A = gene absent, ǂ = genotypes with frequency < 0.01, ¥ = not calculated. (DOCX 33 kb)